Zyus Life Sciences Corporation (TSE:ZYUS) has released an update.
ZYUS Life Sciences Corporation, a company specializing in cannabinoid-based pharmaceuticals for pain management, has announced its participation in the Sidoti May Virtual Investor Conference on May 8-9, 2024. Brent Zettl, President and CEO, will present at the event and engage in one-on-one meetings with investors. The conference provides a platform for ZYUS to showcase its innovations and growth prospects to potential investors.
For further insights into TSE:ZYUS stock, check out TipRanks’ Stock Analysis page.
